# Metagenomi Therapeutics, Inc.: Form 8-K, filed Dec 10, 2024

- Company: [Metagenomi Therapeutics, Inc.](/companies/mgx.md) (CIK 1785279)
- Form: 8-K
- Filed: 2024-12-10
- Accepted by EDGAR: Dec 9, 2024, 21:22 ET
- Period: 2024-12-09
- Accession: 0000950170-24-134733
- Inline XBRL: yes
- Main document: https://www.sec.gov/Archives/edgar/data/1785279/000095017024134733/mgx-20241209.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/1785279/000095017024134733/

## Items reported

- Item 8.01: Other events
- Item 9.01: Financial statements and exhibits

## Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. https://www.sec.gov/Archives/edgar/data/1785279/000095017024134733/mgx-20241209.htm

Filed Dec 10, 2024.
Source: SEC EDGAR, the filing index for accession 0000950170-24-134733. Last ingested by Listed: Oct 24, 2026, 15:15 ET. No prices; not investment advice.